An analysis of blood plasma samples from four people who recovered from SARS-CoV-2 infectionsshows that most of the antibodies circulating in the blood -- on average, about 84% -- target areas of the viral spike protein outside the receptor binding domain (RBD). Courtesy of University of Texas at Austin
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.
Previous research focused on one group of antibodies that target the most obvious part of the coronavirus's spike protein, called the receptor-binding domain (RBD). Because the RBD is the part of the spike that attaches directly to human cells and enables the virus to infect them, it was rightly assumed to be a primary target of the immune system. But, testing blood plasma samples from four people who recovered from SARS-CoV-2 infections, the researchers found that most of the antibodies circulating in the blood -- on average, about 84% -- target areas of the viral spike protein outside the RBD -- and, apparently, for good reason.
"We found these antibodies are painting the entire spike, both the arc and the stalk of the spike protein, which looks a bit like an umbrella," said co-corresponding author Greg Ippolito, who is a research associate professor in UT Austin's Department of Molecular Biosciences and an assistant professor of oncology at the university's Dell Medical School. "The immune system sees the entire spike and tries to neutralize it."
Many of these non-RBD-directed antibodies the team identified act as a potent weapon against the virus by targeting a region in a part of the spike protein located in what would be the umbrella's canopy called the N-terminal domain (NTD). These antibodies neutralize the virus in cell cultures and were shown to prevent a lethal mouse-adapted version of the virus from infecting mice.
The NTD is also a part of the viral spike protein that mutates frequently, especially in several variants of concern. This suggests that one reason these variants are so effective at evading our immune systems is that they can mutate around one of the most common and potent types of antibody in our arsenals.
"There's an evolutionary arms race going on between the virus and our immune systems," said Jason Lavinder, research associate in the McKetta Department of Chemical Engineering and co-corresponding author of the new study. "We're all developing a standard immune response to this virus that includes targeting this one spot and that's exerting selective pressure on the virus. But then the virus is also exerting its evolutionary strength by trying to change around our selective immune pressures."
Despite these maneuvers by SARS-CoV-2, the researchers said about 40% of the circulating antibodies target the stalk of the spike protein, called the S2 subunit, which is also a part that the virus does not seem able to change easily.
"That's reassuring," Ippolito said. "That's an advantage our immune system has. It also means our current vaccines are eliciting antibodies targeting that S2 subunit, which are likely providing another layer of protection against the virus."
That's also good news for designing vaccine boosters or next-generation vaccines against variants of concern, and even for developing a vaccine that can protect against future pandemics from other strains of the coronavirus.
"It means we have a strong rationale for developing next-generation SARS-CoV-2 vaccines or even a pan-coronavirus vaccine that targets every strain," Ippolito said.
UT Austin researchers are among several in the world now aiming to develop a single coronavirus vaccine to fight infection from all coronaviruses, not just SARS-CoV-2.
The first author of the study is William Voss, a graduate student at UT Austin. In addition to Lavinder and Ippolito, senior authors from UT Austin are Jimmy Gollihar, Ilya Finkelstein, Brent Iverson, Jason McLellan and George Georgiou. Georgiou and Ippolito are also affiliated with UT Austin's Dell Medical School. Gollihar is also affiliated with the Army Research Laboratory South.
Collaborating institutions are the University of North Carolina at Chapel Hill, the U.S. Army Medical Research Institute of Infectious Diseases and the Centers for Disease Control and Prevention.
Source: University of Texas at Austin
Greetings from Ohio! I’m bored to death at work so I decided to check out your website on my iphone during lunch break. I enjoy the knowledge you present here and can’t wait to take a look when I get home. I’m amazed at how quick your blog loaded on my cell phone .. I’m not even using WIFI, just 3G .. Anyhow, good site!
Wow, that’s what I was searching for, what a information! present here at this weblog, thanks admin of this web site.
Wow! This blog looks exactly like my old one! It’s on a completely different topic but it has pretty much the same layout and design. Wonderful choice of colors!
I have been surfing online more than three hours lately, yet I never found any interesting article like yours. It’s pretty value enough for me. Personally, if all website owners and bloggers made just right content as you did, the net will be much more useful than ever before.
I always spent my half an hour to read this blog’s articles or reviews everyday along with a cup of coffee.
Its like you read my mind! You seem to know so much about this, like you wrote the book in it or something. I think that you could do with some pics to drive the message home a bit, but other than that, this is magnificent blog. A great read. I’ll definitely be back.
No matter if some one searches for his necessary thing, thus he/she needs to be available that in detail, thus that thing is maintained over here.
I loved as much as you will receive carried out right here. The sketch is tasteful, your authored subject matter stylish. nonetheless, you command get bought an edginess over that you wish be delivering the following. unwell unquestionably come further formerly again since exactly the same nearly a lot often inside case you shield this increase.
I simply could not leave your site prior to suggesting that I really enjoyed the standard information a person supply for your visitors? Is going to be back steadily in order to check out new posts
I constantly spent my half an hour to read this webpage’s articles everyday along with a cup of coffee.
Hmm it appears like your website ate my first comment (it was extremely long) so I guess I’ll just sum it up what I submitted and say, I’m thoroughly enjoying your blog. I as well am an aspiring blog blogger but I’m still new to the whole thing. Do you have any tips and hints for inexperienced blog writers? I’d definitely appreciate it.
We stumbled over here different page and thought I might check things out. I like what I see so now i am following you. Look forward to checking out your web page for a second time.
At this time I am going away to do my breakfast, once having my breakfast coming again to read further news.
Heya i’m for the first time here. I came across this board and I find It truly useful & it helped me out a lot. I hope to give something back and help others like you helped me.
Pretty great post. I simply stumbled upon your blog and wanted to mention that I have really enjoyed browsing your blog posts. In any case I’ll be subscribing on your feed and I hope you write again soon!
Great article! This is the type of information that are meant to be shared around the web. Disgrace on the seek engines for not positioning this publish upper! Come on over and discuss with my web site . Thank you =)
Hey there, You have performed a great job. I will definitely digg it and in my opinion recommend to my friends. I am sure they will be benefited from this site.
I have been surfing online more than 3 hours today, yet I never found any interesting article like yours. It’s pretty worth enough for me. Personally, if all site owners and bloggers made good content as you did, the net will be much more useful than ever before.
What’s Taking place i’m new to this, I stumbled upon this I have found It positively helpful and it has helped me out loads. I hope to give a contribution & assist other users like its helped me. Good job.
Great info. Lucky me I ran across your site by accident (stumbleupon). I have bookmarked it for later!
Very good website you have here but I was curious if you knew of any community forums that cover the same topics talked about in this article? I’d really love to be a part of group where I can get comments from other knowledgeable individuals that share the same interest. If you have any recommendations, please let me know. Cheers!